Form EFFECT Silexion Therapeutics
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 29, 2025 |
| Accession Number: | 0001178913-25-001991 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Huawei Unveils Next-Gen Flagship Products at "Chase the Wild" Global Innovative Product Launch Event in Munich
- SIMZY Launches Europe eSIM Plans, Bringing Unlimited 5G Data to Travelers Across the Continent Without Roaming Fees
- Eluvio Showcases New Advanced Features in Global Broadcast Fabric for Zero-Copy Broadcast Distribution, D2C OTT Streaming & Monetization, and Inline AI Video Intelligence at IBC 2026
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
